IL1RL1/ST2 Cancer Research Results

IL1RL1/ST2, Interleukin-1 Receptor-Like 1 / ST2: Click to Expand ⟱
Source:
Type:

IL1RL1 - Interleukin-1 Receptor-Like 1 / ST2

Abbreviation: IL1RL1, ST2, ST2L

Type: Cytokine receptor / IL-33 receptor

Function: IL1RL1 encodes ST2, the principal receptor for IL-33. Membrane-bound ST2L forms a signaling receptor complex with IL1RAP and transduces IL-33-dependent inflammatory and immune signals. A soluble isoform, sST2, lacks the signaling domain and functions as a decoy receptor that binds extracellular IL-33 and limits IL-33/ST2L signaling.

Cancer: ↕ Context-dependent. ST2-mediated IL-33 signaling can support either tumor-promoting or antitumor immune responses depending on cancer type, immune-cell composition, receptor isoform, and tumor microenvironment.



Scientific Papers found: Click to Expand⟱
7928- H2,    Molecular hydrogen alleviates asthma through inhibiting IL-33/ILC2 axis
- in-vivo, Asthma, NA
*IL33↓, *NF-kB↓, *IL1RL1/ST2↓, *ILC2↓, *E-cadherin↑, *ZO-1↑, *Inflam↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0)

IL1RL1/ST2↓, 1,   ILC2↓, 1,  

Migration(tgid=13)

E-cadherin↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

IL33↓, 1,   Inflam↓, 1,   NF-kB↓, 1,  
Total Targets: 7

Scientific Paper Hit Count for: IL1RL1/ST2, Interleukin-1 Receptor-Like 1 / ST2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1721  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page